Search Results - "(Curly) Morris, T. C. M."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Evolution or revolution in multiple myeloma therapy and the role of the UK by Cook, Gordon, Morris, Curly T. C. M.

    Published in British journal of haematology (01-11-2020)
    “…Summary The knowledge of disease biology as well as the therapeutic landscape in multiple myeloma (MM) has expanded exponentially in recent years. These…”
    Get full text
    Journal Article
  2. 2

    IgD multiple myeloma: biology, diagnosis, and treatment by Egan, Philip A., O'Connor, Sheila J. M., Deighan, W. Ian, McConville, Conal E., Elder, Patrick T., (Curly) Morris, T. C. M., Alexander, H. Denis

    Published in Leukemia & lymphoma (06-12-2022)
    “…IgD multiple myeloma is uncommon. Patients generally present at a younger age and have shorter progression free and overall survivals (OSs). Its rarity has…”
    Get full text
    Journal Article
  3. 3

    ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma by Drain, Stephen, Catherwood, Mark A., Orr, Nick, Galligan, Leeona, Rea, I. Maeve, Hodkinson, Clare, Drake, Mary B., Kettle, Paul J., Morris, T. C. M. "Curly", Alexander, H. Denis

    Published in Leukemia & lymphoma (01-01-2009)
    “…Multi-drug resistance (MDR) may compromise the successful management of haematological malignancies, impairing the effectiveness of chemotherapy. The…”
    Get full text
    Journal Article
  4. 4

    Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia by Galligan, Leeona, Catherwood, Mark A., Matthews, Christine, 'Curly' Morris, T. C. M, Dennis Alexander, H

    Published in Leukemia & lymphoma (01-04-2008)
    “…Biased IgHV gene usage in chronic lymphocytic leukemia (CLL) is well documented and suggests antigen involvement in leukemogenesis. IgHV1-69 is one of the most…”
    Get full text
    Journal Article
  5. 5

    V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis by Matthews, Christine, Catherwood, Mark A, Morris, T C M 'curly', Alexander, H Denis

    Published in Leukemia research (01-02-2007)
    “…This study determined IgV(H) gene usage in 228 chronic lymphocytic leukaemia patients to investigate associations between gene usage and other biological or…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Routine Analysis of IgVH Mutational Status in CLL Patients using BIOMED-2 Standardized Primers and Protocols by Matthews, Christine, Catherwood, Mark A, Morris, TCM 'Curly', Alexander, H Denis

    Published in Leukemia & lymphoma (01-09-2004)
    “…Current methods for the detection of IgVH mutational status in chronic lymphocytic leukemia (CLL), which identifies 2 subgroups of patients with significantly…”
    Get full text
    Journal Article
  10. 10

    MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia by Matthews, Christine, Catherwood, Mark A., Larkin, Anne-Marie, Clynes, Martin, Morris, Tcm 'Curly', Alexander, H. Denis

    Published in Leukemia & lymphoma (01-11-2006)
    “…Two P-glycoprotein (P-gp) genes, MDR-1 (ABCB1) and MDR-3 (ABCB4), have been identified in humans. This study was designed to investigate whether associations…”
    Get full text
    Journal Article
  11. 11

    Improved Laboratory Diagnosis of Bacterial and Fungal Infections in Patients with Hematological Malignancies using PCR and Ribosomal RNA Sequence Analysis by Xu, Jiru, Moore, John E, Millar, B Cherie, Alexander, H Denis, McClurg, Robert, Morris, TCM "Curly", Rooney, Paul J

    Published in Leukemia & lymphoma (01-08-2004)
    “…During October 1999 to November 2000, 98 blood culture specimens from the same number of febrile episodes originating from 49 patients with hematological…”
    Get full text
    Journal Article
  12. 12

    Detection of tumor-derived antigen receptor DNA by polymerase chain reaction in the serum of patients with B-cell chronic lymphocytic leukemia by Catherwood, MA, Wall, JP, Morris, TC, Alexander, HD

    Published in Haematologica (Roma) (01-07-2005)
    “…Tumor-derived DNA is detectable in the serum of patients. In this study, tumor derived and mononuculear cell DNA from 50 patients with B-cell chronic…”
    Get full text
    Journal Article
  13. 13

    Aggressive Natural Killer Cell Leukemia/Lymphoma: Case Report, use of Telesynergy™ and Review of the Literature by Murdock, Joanne, Jaffe, Elaine S, Wilson, Wyndham H, McManus, Damian T, Alexander, H Denis, Morris, TCM "Curly"

    Published in Leukemia & lymphoma (01-06-2004)
    “…Natural killer cell malignancies, although increasingly recognized, remain rare tumors within the USA and Europe. They are somewhat more common in Asia, and…”
    Get full text
    Journal Article